Skip to main content
SUPN logo
SUPN
(NASDAQ)
Supernus Pharmaceuticals, Inc.
$50.48-- (--)
Loading... - Market loading

Supernus Pharmaceuticals (SUPN) Stock Price & Financial Analysis

Supernus Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$50.08 - $51.37
52-Week High$59.68
52-Week Low$29.16
Open$50.49
Volume472.50K
Average Volume (3M)472.50K
Market Cap2.85B
Shares Outstanding56.45M
Price to Sales (P/S)4.04
Price to Book (P/B)0.00
EV/EBITDA-896.60
Revenue (TTM)718.95M
Net Income (TTM)-38.55M
Free Cash Flow (TTM)45.99M
EPS (TTM)$-0.67
Profit Margin-5.36%
Operating Margin-5.13%
Return on Equity (ROE)0.00%
Debt to Equity0.03
50-Day MA$51.03
200-Day MA$45.83
52-Week Change62.37%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Supernus Pharmaceuticals

What is the current stock price for SUPN?

As of the latest trading session, SUPN stock trades at $50.48. The 52-week range is $29.16–$59.68, with a day range of $50.08–$51.37.

What is the P/E ratio for SUPN?

The P/E ratio (Price-to-Earnings) for SUPN is shown in the Key Statistics section. This valuation metric helps compare Supernus Pharmaceuticals, Inc. to industry peers.

Does SUPN pay dividends?

Supernus Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SUPN?

Analyst ratings and recommendations for SUPN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of SUPN?

Supernus Pharmaceuticals's market capitalization is $2.85B, classifying it as a mid-cap company. Supernus Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.